{"schema_version":"alpha-company-profile-public-v2","slug":"ironwood-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc","published_on":"2026-09-14T14:36:31.481633+00:00","last_reviewed_on":"2026-09-14T14:36:31.481633+00:00","identity":{"legal_name":"IRONWOOD PHARMACEUTICALS INC","display_name":"IRONWOOD PHARMACEUTICALS INC","headline":"Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions.","description":"Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the ","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001446847","logo":"https://cdn.brandfetch.io/ticker/irwd/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/irwd/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"IRONWOOD PHARMACEUTICALS INC logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-14T14:36:31.481633+00:00"},"security_listings":[{"ticker":"IRWD","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"IRONWOOD PHARMACEUTICALS INC","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"},{"label":"Industry","value":"Drug Manufacturers - Specialty & Generic","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/ironwood-pharmaceuticals-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-14T14:36:31.481633+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":23,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":23,"corroborated_claims":0,"sources":3,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-14T14:36:31.481633+00:00","observed_at":"2026-09-14T14:36:31.481633+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"ironwood-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc"},"publication":{"published_at":"2026-09-14T14:36:31.481633+00:00","last_reviewed_at":"2026-09-14T14:36:31.481633+00:00","as_of":"2026-09-14T14:36:31.481633+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/ironwood-pharmaceuticals-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"ironwood-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc","as_of":"2026-09-14T14:36:31.481633+00:00","last_reviewed_at":"2026-09-14T14:36:31.481633+00:00","identity":{"legal_name":"IRONWOOD PHARMACEUTICALS INC","display_name":"IRONWOOD PHARMACEUTICALS INC","description":"Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the ","jurisdiction":null,"country":"US","sector":"Healthcare","industry":"Drug Manufacturers - Specialty & Generic","website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001446847","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"IRWD","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"51e01b79-6558-4989-8d91-e8c901790153","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-15","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"julie-mchugh-ironwood-pharmaceuticals-inc","display_name":"Julie McHugh","role_category":"director","title":"Chair of the Board","committee":null,"is_board_chair":true,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"alexander-denner-irwd","display_name":"Alexander Denner","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A tm261380-1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T01:12:52.556227+00:00"},"headshot_url":null},{"person_slug":"alexander-denner-ph-d","display_name":"Alexander Denner, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"catherine-moukheibir-irwd","display_name":"Catherine Moukheibir","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A tm261380-1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T01:12:52.556227+00:00"},"headshot_url":null},{"person_slug":"gregory-martini-irwd","display_name":"Gregory Martini","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A tm261380-1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T01:12:52.556227+00:00"},"headshot_url":null},{"person_slug":"jay-shepard","display_name":"Jay Shepard","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"john-minardo-irwd","display_name":"John Minardo","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A tm261380-1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T01:12:52.556227+00:00"},"headshot_url":null},{"person_slug":"jon-duane-irwd","display_name":"Jon Duane","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A tm261380-1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T01:12:52.556227+00:00"},"headshot_url":null},{"person_slug":"mark-currie-ph-d","display_name":"Mark Currie, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"marla-kessler","display_name":"Marla Kessler","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"moukheibir-jay-shepard-irwd","display_name":"Moukheibir Jay Shepard","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A tm261380-1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T01:12:52.556227+00:00"},"headshot_url":null},{"person_slug":"tammi-gaskins-irwd","display_name":"Tammi Gaskins","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A tm261380-1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T01:12:52.556227+00:00"},"headshot_url":null},{"person_slug":"thomas-mccourt-ironwood-pharmaceuticals-inc","display_name":"Thomas McCourt","role_category":"director","title":"Director, Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null}],"executives":[{"person_slug":"gregory-martinez","display_name":"Gregory Martinez","role_category":"executive","title":"Senior Vice President, Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"john-minardo-irwd","display_name":"John Minardo","role_category":"executive","title":"Senior Vice President, Chief Legal Officer and Secretary","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"michael-shetzline-m-d-ph-d","display_name":"Michael Shetzline, M.D., Ph.D.","role_category":"executive","title":"Senior Vice President, Chief Medical Officer and Head of Research and Drug Development","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"tammy-gaskins","display_name":"Tammy Gaskins","role_category":"executive","title":"Senior Vice President, Chief Commercial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null},{"person_slug":"thomas-mccourt-ironwood-pharmaceuticals-inc","display_name":"Thomas McCourt","role_category":"executive","title":"Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001104659-26-050325","source_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926050325/tm261380-1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T08:38:28.365637+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc#profile","url":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc","dateModified":"2026-09-14T14:36:31.481633+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc#organization","legalName":"IRONWOOD PHARMACEUTICALS INC","name":"IRONWOOD PHARMACEUTICALS INC","description":"Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the ","url":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Chair of the Board","member":{"@type":"Person","name":"Julie McHugh","url":"https://registry.alpha.ac/people/julie-mchugh-ironwood-pharmaceuticals-inc"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Alexander Denner","url":"https://registry.alpha.ac/people/alexander-denner-irwd"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Alexander Denner, Ph.D.","url":"https://registry.alpha.ac/people/alexander-denner-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Catherine Moukheibir","url":"https://registry.alpha.ac/people/catherine-moukheibir-irwd"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-28","member":{"@type":"Person","name":"Gregory Martini","url":"https://registry.alpha.ac/people/gregory-martini-irwd"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Jay Shepard","url":"https://registry.alpha.ac/people/jay-shepard"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-28","member":{"@type":"Person","name":"John Minardo","url":"https://registry.alpha.ac/people/john-minardo-irwd"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Jon Duane","url":"https://registry.alpha.ac/people/jon-duane-irwd"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Mark Currie, Ph.D.","url":"https://registry.alpha.ac/people/mark-currie-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Marla Kessler","url":"https://registry.alpha.ac/people/marla-kessler"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Moukheibir Jay Shepard","url":"https://registry.alpha.ac/people/moukheibir-jay-shepard-irwd"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-28","member":{"@type":"Person","name":"Tammi Gaskins","url":"https://registry.alpha.ac/people/tammi-gaskins-irwd"}},{"@type":"OrganizationRole","roleName":"Director, Chief Executive Officer","member":{"@type":"Person","name":"Thomas McCourt","url":"https://registry.alpha.ac/people/thomas-mccourt-ironwood-pharmaceuticals-inc"}},{"@type":"OrganizationRole","roleName":"Senior Vice President, Chief Financial Officer","member":{"@type":"Person","name":"Gregory Martinez","url":"https://registry.alpha.ac/people/gregory-martinez"}},{"@type":"OrganizationRole","roleName":"Senior Vice President, Chief Legal Officer and Secretary","member":{"@type":"Person","name":"John Minardo","url":"https://registry.alpha.ac/people/john-minardo-irwd"}},{"@type":"OrganizationRole","roleName":"Senior Vice President, Chief Medical Officer and Head of Research and Drug Development","member":{"@type":"Person","name":"Michael Shetzline, M.D., Ph.D.","url":"https://registry.alpha.ac/people/michael-shetzline-m-d-ph-d"}},{"@type":"OrganizationRole","roleName":"Senior Vice President, Chief Commercial Officer","member":{"@type":"Person","name":"Tammy Gaskins","url":"https://registry.alpha.ac/people/tammy-gaskins"}},{"@type":"OrganizationRole","roleName":"Chief Executive Officer","member":{"@type":"Person","name":"Thomas McCourt","url":"https://registry.alpha.ac/people/thomas-mccourt-ironwood-pharmaceuticals-inc"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/ironwood-pharmaceuticals-inc"},"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"}},"canonical_source":"aegis_canonical"}